--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
MicroStrategy
MSTR
NVIDIA
NVDA
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
US Stock MarketDetailed Quotes
ANRO Alto Neuroscience
- 3.890
- +0.170+4.57%
Close Dec 20 16:00 ET
- 3.940
- +0.050+1.29%
Post 20:01 ET
104.91MMarket Cap-1.83P/E (TTM)
3.930High3.650Low461.75KVolume3.650Open3.720Pre Close1.77MTurnover2.38%Turnover RatioLossP/E (Static)26.97MShares24.00052wk High0.64P/B75.47MFloat Cap3.56052wk Low--Dividend TTM19.40MShs Float24.000Historical High--Div YieldTTM7.53%Amplitude3.560Historical Low3.842Avg Price1Lot Size
Alto Neuroscience Key Stats
Alto Neuroscience Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Alto Neuroscience Earnings Reports
Read more
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Analysis
Price Target
No Data